Portugal offers free HPV vaccine to girls
The decision by Portugal to include free human papillomavirus vaccination for pre-adolescent and adolescent girls in the 2008 national vaccination calendar has been welcomed by Sanofi Pasteur MSD, which markets US drug major Merck & Co's Gardasil HPV vaccine in the European Union.
"This is great news for women in Portugal," according to Didier Hoch, president of Sanofi Pasteur MSD. He added: "this program...will help save the lives of many women... and improve the health of even more women who suffer from other human papillomavirus-related genital diseases."
Portugal's Prime Minister, Jose Socrates, told the Parliament that access to vaccination will not depend on family income. A public procurement process will be set up in December, allowing the government to choose an HPV vaccine, he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze